During the chronic phase of AD, cytokines derived from Th17 and Th22 cells—such as IL-17 and IL-22—contribute to sustained inflammation and epidermal hyperplasia via both JAK-STAT-dependent and independent pathways. Here, IL22 is linked to Alzheimer disease.